StageZero is making lots of money with COVID testingand many are so focus on Aristotle that they only see Aristotle....I see a company that is cash positive thanks to COVID testing (Thanks to Tripp who took the most important decision in 2020).
Yes Aristotle is the main product that will drive this company to success and in short term COVID testing is the BIG income they have until Aristotle take over with more cancer testing done.
Just think for a second, how many R&D in the bio sector are cash positive while creating a new product.....more likely heavy on debt with many shares on circulation. StageZero has this opportunity of breathing fresh air without any stress of having to survive financially. What they have achieve is a milestone and the next step is Aristotle launch with so many client ALREADY familiar with StageZero because of COVID testing!!!!!!
That was my 2 cents of fundamental analysis of the day!
One last day left after Today before I take my break and see you all next September Yeahhhhhh :-)